ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,863, issued on Sept. 1, was assigned to The Texas A&M University System (College Station, Texas) and The Trustees of Indiana University (Bloomington, Ind.).

"Treatment for down syndrome-related accelerated aging" was invented by Thomas A Kent (Houston), Paul J. Derry (Houston) and Kenneth R. Olson (Berrien Springs, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a Down syndrome (DS) subject with functional or at risk of decline of organ systems associated with accelerated aging due to over-production of H2S is disclosed. That method contemplates administering a pharmaceutical composition containing a H2S-reducing effective ...